Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Portopulmonary Hypertension”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Large-scale testing (Phase 3)Study completedNCT01224210
What this trial is testing

Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial

Who this might be right for
Portopulmonary Hypertension
Tufts Medical Center 30
Not applicableNot Yet RecruitingNCT07314814
What this trial is testing

Genetic Hallmarks of Patients With Congenital Portosystemic Shunts and Portopulmonary Hypertension

Who this might be right for
Portopulmonary HypertensionPulmonary Arterial Hypertension (PAH)Congenital Portosystemic Shunt
Prof. Valérie Mc Lin 120
Post-approval studies (Phase 4)Study completedNCT02382016
What this trial is testing

PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical Trial

Who this might be right for
Portopulmonary Hypertension
Actelion 85
Testing effectiveness (Phase 2)Ended earlyNCT00145938
What this trial is testing

Sildenafil and Pulmonary Artery Pressure

Who this might be right for
Pulmonary Hypertension
University of Chicago 10
Testing effectiveness (Phase 2)WithdrawnNCT01733095
What this trial is testing

Ambrisentan for Treatment of Portopulmonary Hypertension

Who this might be right for
Portopulmonary Hypertension
Medical University of Graz
Post-approval studies (Phase 4)WithdrawnNCT03309592
What this trial is testing

Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary Hypertension

Who this might be right for
Portopulmonary HypertensionPulmonary HypertensionCirrhosis, Liver
Ochsner Health System
Not applicableStudy completedNCT01028651
What this trial is testing

Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension

Who this might be right for
Portopulmonary HypertensionPulmonary Arterial HypertensionPulmonary Hypertension
United Therapeutics 13
Testing effectiveness (Phase 2)Ended earlyNCT01517854
What this trial is testing

Revatio Portal-Pulmonary Arterial Hypertension Trial

Who this might be right for
Portopulmonary Hypertension
University Health Network, Toronto 12